For years, the intersection of artificial intelligence and healthcare has been defined by a frustrating paradox: the technology to revolutionize patient care exists, but the financial mechanism to pay for it does not. In the rigid world of government reimbursement, if there isn’t a specific “billing code” for a service, that service effectively doesn’t exist in the eyes of the payer.
However, a quiet but fundamental shift in how Medicare handles payments is creating a massive opening for AI. While most of Silicon Valley is hunting for a “per-user” government fee or a new regulatory loophole, the real opportunity lies in a transition toward value-based care. This model moves away from paying for individual tasks and instead pays for the overall health of a patient—effectively creating a financial environment where AI agents can finally be deployed and paid for at scale.
As a former software engineer turned journalist, I have watched the “AI in health” space be dominated by diagnostic tools and administrative automation. But the most significant disruption isn’t happening in the clinic. it’s happening in the payment ledger. By shifting the financial incentive from volume to value, Medicare is inadvertently building the perfect infrastructure for autonomous AI agents to manage the “white space” between doctor visits.
The ‘CPT Code’ Bottleneck: Why Traditional Medicare Blocks AI
To understand why Here’s a breakthrough, one must first understand the “Current Procedural Terminology” (CPT) system. For decades, Medicare has operated primarily on a fee-for-service (FFS) model. In this system, a provider performs a specific action—like a blood draw or a 15-minute consultation—and bills a specific CPT code to get paid.
The problem is that there is no CPT code for “AI agent monitored patient’s mood via voice analysis,” “AI coordinated a housing referral for a homeless senior,” or “AI bot checked in on a patient to ensure they picked up their heart medication.” Because these actions don’t fit into the legacy billing boxes, providers have had no way to recoup the costs of deploying such technology. They were essentially asked to innovate for free.
This bottleneck has forced tech companies to target the “administrative” side of healthcare—billing and scheduling—because those are the only areas where the financial incentives align with the current system. The actual care coordination, the critical work that happens between appointments, has remained a manual, underfunded struggle.
The Shift to Value-Based Care and the ‘ACCESS’ Logic
The game changes with the rise of value-based care (VBC), specifically through initiatives like the ACO REACH (Accountable Care REACH) model. Unlike fee-for-service, these models provide healthcare organizations with a benchmarked budget to manage a population of patients. If the organization keeps the patients healthier and reduces expensive emergency room visits, they share in the savings.
In this environment, the “billing code” no longer matters. The provider isn’t asking, “How do I bill for this AI agent?” Instead, they are asking, “Will this AI agent reduce the likelihood of my patient being hospitalized?”
This is the “mechanism” that has been missing. When a provider is paid for the outcome rather than the action, the AI agent becomes a high-ROI investment. An AI that can call a patient, detect early signs of congestive heart failure through voice biomarkers and coordinate a housing referral to prevent a relapse is no longer a “cost center”—it is a tool for financial sustainability.
Bridging the Gap in Social Determinants of Health (SDOH)
One of the most profound impacts of this shift is in the management of Social Determinants of Health (SDOH). Clinical care only accounts for a small fraction of a patient’s health outcomes; the rest is determined by where they live, what they eat, and their access to transportation.
